Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.57M$2.57Mderived−26.0% vs Q4 2024 Net Income-$379.75K-$379.75KderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$371,769N/M Operating Cash Flowderived$15,760N/M Free Cash Flowderived$11,880N/M Margins · derivedOperating margin-14.5%−18.4 pt vs Q4 2024
Net margin-14.8%−18.6 pt vs Q4 2024
ended Jun 30, 2025 · filed Sep 29, 2025 · 91 d after period end